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INTRODUCTION
Dehydroepiandrosterone (DHEA), also known 
as Prasterone (INN) is an important endogenous ste-
roid hormone. It functions primarily as a metabolic 
intermediate in the biosynthesis of androgenic and 
estrogenic sex steroids (1,2). DHEA is a precursor of 
important both female and male hormones. DHEA 
supplementation is used to energise the body in ath-
letes and people undergoing physical activity; to im-
prove memory and concentration of attention; to ac-
tivate the immune system; to increase testosterone 
levels in the body. Clinical studies have demonstrat-
ABSTRACT
A normal-phase High Performance Liquid Chromatography (HPLC) method was developed for the determi-
nation of dehydroepiandrosterone (DHEA) in food supplements. We have used an HPLC 200 (Perkin Elmer, 
USA) with a spectrophotometric detector LC-785A (Bioanalytical systems, USA) and a thermostat (Perkin 
Elmer, Waltham, MA, USA). We have chosen isocratic HPLC elution, column: LiChrospher (100 DIOL 250 
x 4 mm х 5 µm), mobile phase: acetonitrile: water = 98: 2 v/v, flow rate: 1 ml/min. and detection at λ = 202 
nm. We have found that this method allows fast and selective qualitative and quantitative determination of 
DHEA in pharmaceutical products.
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ed that the use of DHEA leads to improved mood, 
increased resistance to stress, improved sleep quality, 
as well as benefit male and female individuals in pre-
menopausal and postmenstrual age (3,4,5,6,16,17). 
Legislative frameworks relating to DHEA world-
wide are very controversial: some countries even 
banned imports of DHEA products, in others it may 
be granted only on prescription for medical purposes 
and is a controlled substance; also there are countries 
in which DHEA is sold and distributed freely as a di-
etary supplement. In Bulgaria, DHEA is available as 
a dietary supplement. The procedure for registration, 
sale and control is extremely liberal. DHEA products 
are sold as food supplements and can be purchased 
at pharmacies, drugstores, grocery stores and via 
the Internet. DHEA is a prohibited substance by the 
World Anti-Doping Agency. Gas chromatography 
with mass spectrometry and liquid chromatography 
with mass spectrometry are used for the detection 
of DHEA and its metabolites in biological samples 
(7,8,9,10). The High Performance Liquid Chroma-
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tography (HPLC) method is most commonly used to 
determine DHEA in food additives (11,12,13,14,15). 
The reversed-phase HPLC is most commonly used 
option, described in the scientific literature, for the 
chromatographic determination of DHEA. The hy-
drophobic properties of DHEA also allow the appli-
cation of a normal phase liquid chromatography.
МATERIALS AND METHODS 
Мaterials 
І) Reference standard: trans-Dehydroandros-
terone ≥99% (Sigma-Aldrich)
ІI) Reagents with analytical grade quality: ace-




HPLC 200 (Perkin Elmer, USA) with: spectro-
photometric detector LC-785A (Bioanalytical sys-
tems, USA); thermostat (Perkin Elmer, Waltham, 
MA, USA); ultrasonic bath (Branson Wilmington, 
NC, USA); apparatus for ultrapure water: “Milli-Q”, 
“Milipore” (Bedford, MA, USA) and “Elga” (VWR 
International, Randor, PA, USA).
II) Chromatographic conditions: isocratic 
HPLC elution at: stationary phase: column: LiChro-
spher (100 DIOL 250 x 4 mm х 5 µm), mobile phase: 
acetonitrile: water = 98: 2 v/v, flow rate: 1 ml/min., 
detection at λ = 202 nm.
III) Preparation of solutions of substances:
1. Preparation of stock standard solution of 
DHEA. An accurately weighed quantity (4.1 
mg) of reference substance Dehydroandros-
terone was dissolved in 20 ml acetonitrile un-
der sonication in ultrasonic bath. After di-
lution with acetonitrile in a volumetric f lask 
of 50.0 ml, a solution with a concentration 
of Dehydroandrosterone 82 μg/ml was ob-
tained. The solution is stable for more than a 
week under refrigeration (4÷8°C).
2. Preparation of a solution of sample 1. An 
amount equivalent to 28.7 mg DHEA was 
weighed from crushed tablet mass, 20 ml of 
acetonitrile were added and the sample was 
sonicated 5 min. in an ultrasonic bath with 
stirring periodically. The resulting suspen-
sion was diluted in a volumetric f lask 50.0 ml 
with acetonitrile. The solution was filtered 
through a 0.45 μm membrane filter and anal-
ysed by the described HPLC method.
3. Preparation of a solution of sample 2. 
An amount equivalent to 18 mg DHEA was 
weighed from crushed tablet mass, 20 ml of 
acetonitrile were added and the sample was 
sonicated 5 min. in an ultrasonic bath, stir-
ring periodically. The resulting suspension 
was diluted in a volumetric f lask 50.0 ml 
with acetonitrile. The solution was filtered 
through a 0.45 μm membrane filter and anal-
ysed by the described HPLC method.
RESULTS AND DISCUSSION:
The most commonly used method to determine 
DHEA is the reversed-phase HPLC. We have found 
that the hydrophobic properties of DHEA allow the 
use of normal-phase HPLC. We have tried some dif-
ferent types of chromatographic separation to find 
the most appropriate one for the determination of 
DHEA in food supplements. Figures 1, 2 and 3 show 
chromatograms of standard substance of DHEA, ob-
tained with different types of chromatographic sepa-
ration (using different types of chromatographic col-
umns). We have found that the normal-phase HPLC 
shows higher selectivity, therefore we have chosen 
this method for determination of DHEA in the sam-
ples. The use of a spectrophotometric detector in this 
method was a bit difficult. The spectrophotometric 
detection is hindered by the lack of intense optical 
absorption of DHEA in the operating range of the 
wavelength (220 nm and above). The intense optical 
absorption of DHEA is displaced in the far ultraviolet 
region - 190 - 205 nm. To accomplish a high sensitivi-
ty, the detection was performed at 202 nm. For deter-
mination of DHEA we have used a mobile phase con-
taining 98% acetonitrile, especially clean (“Gradient 
grade”), and 2% ultrapure water. Flow rate: 1 ml/min. 
Under these conditions, we built a standard schedule 
for DHEA by obtaining chromatograms of  a series of 
standard solutions with a concentration of 0.8 μg/ml 
to 80 μg/ml, from which the linear range and sensi-
tivity in normal-phase chromatographic determina-
tion of DHEA with spectrophotometric detection at 
202 nm was determined (Figure 4). Figures 6 and 7 
represent the chromatograms of the analyzed sam-
ples, obtained by using normal-phase HPLC.
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We have validated the described method on the 
following validation parameters: linearity, limit of 
detection (LOD) and repeatability.
We built a standard graphic for DHEA by ob-
taining chromatograms of a series of standard solu-
tions with a concentration from 0.8 μg/ml to 80 μg/
ml. We determined the linear range though normal-
phase chromatographic determination of DHEA 
with spectrophotometric detection at 202 nm (Fig. 
4). In the concentration range 0.8÷80 μg/ml the stan-
Figure 1. Chromatogram of a standard solution of DHEA 
obtained by reverse-phase chromatography on a C18 col-
umn with a modified silica (Nova Pack C18, 150 x 4.6 mm 
5 um)
Figure 2. Chromatogram of a standard solution of DHEA 
obtained by reverse-phase chromatography on a column 
of C18-modified organic vehicle (Gemini-NX C18, 150 
mm x 2 mm 3 μm)
Figure 3. Chromatogram of a standard solution of DHEA 
obtained by normal-phase chromatography, column 
DIOL, 250 x 4 mm, 10 μm
Figure 4. Dependence of the surface of the chromato-
graphic peak on the concentration of DHEA, construct-
ed by the introduction of 5 μl standard solutions with con-
centrations of 0.8, 4.8, 16, 50, 82 and 164 μg/ml
Figure 5. Chromatogram of 5 μl standard solution of 
DHEA with concentration 0.8 μg/ml
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dard schedule is linear with a correlation coefficient 
R = 0.9989 equation y = 8544.76 + 2375.04 
The LOD was established by the chromato-
grams of solutions of DHEA with decreasing concen-
tration, until the height of the chromatographic peak 
became commensurable with the noise of the detec-
tor. Figure 5 shows a chromatogram of the standard 
solution with a concentration of DHEA 0.8 μg/ml (4 
ng introduced amount of DHEA), which was calcu-
lated from the amount administered, wherein the 
peak of DHEA is 3 times the noise: 2 ng as a limit of 
detection. The repeatability of the method was estab-
lished by a tenfold input of 10 μl of solution of sample 
1 in 50 ml of acetonitrile in the apparatus for analy-
sis and measurement of the peak area of DHEA. We 
Figure 6. Chromatogram of the analyzed sample 1 Figure 7. Chromatogram of the analyzed sample 2
Sample DHEA content in 1 
capsule (declared on the 
label of the product)
Origin of the 
manufacturer 
Content of DHEA in 1 
capsule (results of the 
analysis)
Sample 1 50mg Bulgaria 47mg ±5μg 
Sample 2 50mg USA 28mg ±5μg 
Table 1. Total content of DHEA in the analyzed food supplements











Table 2. Repeatability of the normal-phase HPLC method for determination of DHEA in food supplements
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have calculated the average peak area, the standard 
deviation σ and the relative standard deviation RSD. 
The data is presented in Table 2.
CONCLUSION
The interest in food supplements and their con-
sumption is growing. This requires stronger mea-
sures for quality control of the dietary supplements. 
DHEA supplementation is commonly used in sports 
because of its high performance-enhancing poten-
tial. In this work we have developed a normal-phase 
HPLC method for detection and quality control of 
food additives containing DHEA. We have found 
that the normal-phase HPLC method for determi-
nation of DHEA is better than the reversed-phase 
HPLC because it provides higher selectivity and al-
lows successful and quick separation of  DHEA from 
the accompanying non-polar impurities. We have 
found that normal-phase HPLC is faster than re-
verse phase HPLC when analyze DHEA products. 
We have validated the described method on the fol-
lowing validation parameters: linearity, limit of de-
tection (LOD) and repeatability to confirm that the 
procedure employed for a specific test is suitable for 
its intended use.
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